President Donald Trump said the U.S. government could start distributing a coronavirus vaccine as early as October, a much more optimistic estimate than his own health officials have publicly advised.
“We’re very close to that vaccine as you know and I think much closer than I think most people want to say,” Trump said during a White House press briefing Wednesday. “We think we can start some time in October. So as soon as it’s announced we’ll be able to start. That will be from mid-October on. It may be a little bit later than that.”
He said the U.S. has manufactured all of the necessary supplies and health officials will be able to distribute at least 100 million vaccine doses by the end of the year. The vaccine could be distributed starting in October or November, but he said “I don’t think it’s going to be too much later than that.”
Earlier in the day, Dr. Robert Redfield told lawmakers at a Senate hearing he expects vaccinations to begin in November or December, but in limited quantities with those most in need getting the first doses, such as health-care workers and the elderly. Redfield, the director of the Centers for Disease Control and Prevention, said it will take about “six to nine months” to get the entire American public vaccinated and that the U.S. would be able to resume “regular life” by the third quarter of next year.
The CDC also outlined a sweeping plan Wednesday to make vaccines for Covid-19 free to all Americans. In the plan, the CDC said it anticipates a coronavirus vaccine will initially be granted an emergency use authorization before a full formal approval.
Trump said Redfield was mistaken when he said the vaccine wouldn’t be widely available to the general public until next summer or early fall.
“I think he made a mistake when he said that. It’s just incorrect information and I called him and he didn’t tell me that and I think he got the message maybe confused, maybe it was stated incorrectly,” Trump said. “We’re ready to go immediately as the vaccine is announced and it could be announced in October, it could be announced a little bit after October but once we go we’re ready.”
Trump said he got the “impression” Redfield “didn’t realize” what he said.
“I didn’t see him say it, but if that’s what he said then it’s a mistake because … we’re ready to distribute immediately to a vast section of our country and then beyond because we want to help other countries also but we’re ready to distribute immediately,” Trump said.
He also disputed Redfield’s comments that face masks may provide more protections than vaccines, saying, “maybe he misunderstood” the question.
“The mask is not as important as the vaccine,” Trump said. “As far as the mask is concerned I hope that the vaccine’s going to be a lot more beneficial than the masks because people have used the masks.”
The CDC did not immediately respond to request for comment on Trump’s remark.
Trump also said he thinks drugmakers are having “tremendous success” with vaccines.
“The results will be early and strong. The safety has to be 100% and we’re going to insist on that and the companies are going to insist on that as well,” he said.
Trump’s remark comes as infectious disease experts and scientists in recent weeks have said they have concerns that the White House may be pressuring the Food and Drug Administration to approve a vaccine before it’s been adequately tested. There are currently no approved vaccines and at least three drugmakers expect to know if their potential vaccines work by the end of the year.
Dr. Anthony Fauci, the nation’s leading infectious disease expert, has said it’s “conceivable” but unlikely the U.S. will have a safe and effective vaccine by October.
Whichever vaccine is authorized by the FDA, it will likely be in short supply once it’s cleared for public distribution, medical experts warn. The vaccine will likely require two doses at varying intervals, and states still face logistical challenges such as setting up distribution sites and acquiring enough needles, syringes and bottles needed for immunizations.
When larger quantities of vaccine become available, the CDC said, there will be two simultaneous objectives: to provide widespread access to vaccination and to ensure high uptake in target populations, particularly those who are at high risk of death or complications from Covid-19.
“The CDC’s goal is to have enough Covid-19 vaccine for all in the United States who wish to be vaccinated,” Redfield said.
Even if a vaccine is ready to be distributed by the end of the year, numerous polls now suggest Americans would be hesitant to get one.
Just 42% of Americans say they would want a vaccine, according to a poll from the nonpartisan Kaiser Family Foundation released this month, short the 60% to 80% of the population epidemiologists say is needed to achieve so-called herd immunity and suppress the virus.
CNBC’s Kevin Breuninger contributed to this article.